News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Migraine Patch Maker NuPathe Inc. Files for $86.3M IPO
May 17, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Businessweek -- Specialty pharmaceutical company NuPathe Inc., which is developing a patch that treats migraines, on Friday filed for an initial public offering valued at up to $86.3 million.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Earnings
Gilead Still Hungry for Deals as HIV Portfolio Grows, Veklury Crashes
October 31, 2025
·
2 min read
·
Tristan Manalac
IPO
Evommune Joins IPO Class With Planned $160M Raise for Immuno Pipeline
October 31, 2025
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
UPDATE: Novo Nordisk Seeks To Steal Metsera From Pfizer With $8.5B Offer
October 30, 2025
·
4 min read
·
Annalee Armstrong
Earnings
Novartis CEO Says Trump’s Drug Pricing Deals Don’t Address Root Problem
October 28, 2025
·
3 min read
·
Annalee Armstrong
